Marchex (FRA:NHM) 5-Year EBITDA Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NHM Marchex Inc FRA:NHM
57 GF Score
Price €1.52
GF Value €1.36
! 6 Warning Signs
View Full Analysis

What is Marchex 5-Year EBITDA Growth Rate?

Marchex FRA:NHM -0.65% 57 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates FRA:NHM with a GF Score™ of 57/100 and a GF Value™ of €1.36. The stock has 6 warning signs investors should review.

Marchex's EBITDA per Share for the three months ended in Jun. 2026 was €-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 25.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Marchex was 781.90% per year. The lowest was -112.50% per year. And the median was 12.40% per year.

Marchex  (FRA:NHM) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Marchex 5-Year EBITDA Growth Rate Related Terms

FRA:NHM vs HFUS, TC, FLNT: 5-Year EBITDA Growth Rate Comparison

For the Advertising Agencies subindustry, Marchex's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marchex 5-Year EBITDA Growth Rate vs Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, Marchex's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Marchex's 5-Year EBITDA Growth Rate falls into.


FRA:NHM
57GF Score
Marchex Inc FRA:NHM
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marchex 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Marchex (FRA:NHM) has a 5-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Marchex and its competitors.
Is Marchex's 5-Year EBITDA Growth Rate too high?
Marchex's current 5-Year EBITDA Growth Rate is 0.00%. Overall, Marchex has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Marchex's 5-Year EBITDA Growth Rate compare to HFUS and TC?
Marchex's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Media - Diversified company?
A good 5-Year EBITDA Growth Rate depends on the Media - Diversified industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Marchex and its competitors. Marchex's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marchex stock overvalued right now?
Marchex (FRA:NHM) has a current 5-Year EBITDA Growth Rate of 0.00%. The stock's GF Value™ is €1.36, compared to a current price of €1.52 — trading 11.8% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. Marchex's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Marchex (FRA:NHM), the current 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Marchex (FRA:NHM) Overvalued in 2026?

Based on GuruFocus' analysis, Marchex stock appears to be overvalued. The current stock price of €1.52 is trading 11.8% above its estimated GF Value™ of €1.36.

Key valuation signals for FRA:NHM:

  • 5-Year EBITDA Growth Rate: 0.00%
  • GF Value™: €1.36 vs. price of €1.52 (11.8% above fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the FRA:NHM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Marchex Business Description

Other Exchanges MCHX:USA
Address 1200 5th Avenue, Suite 1300, Seattle, WA, USA, 98101
Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.
57GF Score

Get the complete analysis for FRA:NHM

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.52
Price
€1.36
GF Value